The pivotal role of timing of intravenous thrombolysis bridging treatment prior to endovascular thrombectomy.

Ther Adv Neurol Disord · 2023 · PMC10725133 · PMID 38107442

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

nearly significantp = 0.064so close (0.05 < p ≤ 0.1)

In a multivariate analysis, bridging therapy remained significantly associated with HT [OR 6.25 (1.61–24.24), p = 0.008), parenchymal hemorrhagic transformation [OR 7.32 (1.26–42.51), p = 0.027], and had a nearly significant trend for unfavorable outcome [OR = 2.37 (0.95–5.93), p = 0.064, Supplemental Table 3 ).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.